Global Opioids Market Insights and Forecast to 2026

Global Opioids Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Opioids Product Introduction
1.2 Market Segments
1.3 Key Opioids Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Opioids Market Size Growth Rate by Type
1.4.2 Immediate-Release/Short-Acting Opioid
1.4.3 Extended-Release/Long-Acting Opioid
1.5 Market by Application
1.5.1 Global Opioids Market Size Growth Rate by Application
1.5.2 Pain Relief
1.5.3 Anesthesia
1.5.4 Cough Suppression
1.5.5 Diarrhea Suppression
1.5.6 Deaddiction
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioids Market Size, Estimates and Forecasts
2.1.1 Global Opioids Revenue 2015-2026
2.1.2 Global Opioids Sales 2015-2026
2.2 Global Opioids, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Opioids Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Opioids Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Opioids Competitor Landscape by Players
3.1 Opioids Sales by Manufacturers
3.1.1 Opioids Sales by Manufacturers (2015-2020)
3.1.2 Opioids Sales Market Share by Manufacturers (2015-2020)
3.2 Opioids Revenue by Manufacturers
3.2.1 Opioids Revenue by Manufacturers (2015-2020)
3.2.2 Opioids Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Opioids Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Opioids Revenue in 2019
3.2.5 Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Opioids Price by Manufacturers
3.4 Opioids Manufacturing Base Distribution, Product Types
3.4.1 Opioids Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioids Product Type
3.4.3 Date of International Manufacturers Enter into Opioids Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opioids Market Size by Type (2015-2020)
4.1.1 Global Opioids Sales by Type (2015-2020)
4.1.2 Global Opioids Revenue by Type (2015-2020)
4.1.3 Opioids Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Opioids Market Size Forecast by Type (2021-2026)
4.2.1 Global Opioids Sales Forecast by Type (2021-2026)
4.2.2 Global Opioids Revenue Forecast by Type (2021-2026)
4.2.3 Opioids Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Opioids Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Opioids Market Size by Application (2015-2020)
5.1.1 Global Opioids Sales by Application (2015-2020)
5.1.2 Global Opioids Revenue by Application (2015-2020)
5.1.3 Opioids Price by Application (2015-2020)
5.2 Opioids Market Size Forecast by Application (2021-2026)
5.2.1 Global Opioids Sales Forecast by Application (2021-2026)
5.2.2 Global Opioids Revenue Forecast by Application (2021-2026)
5.2.3 Global Opioids Price Forecast by Application (2021-2026)
6 North America
6.1 North America Opioids by Country
6.1.1 North America Opioids Sales by Country
6.1.2 North America Opioids Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Opioids Market Facts & Figures by Type
6.3 North America Opioids Market Facts & Figures by Application
7 Europe
7.1 Europe Opioids by Country
7.1.1 Europe Opioids Sales by Country
7.1.2 Europe Opioids Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioids Market Facts & Figures by Type
7.3 Europe Opioids Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Opioids by Region
8.1.1 Asia Pacific Opioids Sales by Region
8.1.2 Asia Pacific Opioids Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Opioids Market Facts & Figures by Type
8.3 Asia Pacific Opioids Market Facts & Figures by Application
9 Latin America
9.1 Latin America Opioids by Country
9.1.1 Latin America Opioids Sales by Country
9.1.2 Latin America Opioids Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Opioids Market Facts & Figures by Type
9.3 Central & South America Opioids Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Opioids by Country
10.1.1 Middle East and Africa Opioids Sales by Country
10.1.2 Middle East and Africa Opioids Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Opioids Market Facts & Figures by Type
10.3 Middle East and Africa Opioids Market Facts & Figures by Application
11 Company Profiles
11.1 Purdue Pharma L.P.
11.1.1 Purdue Pharma L.P. Corporation Information
11.1.2 Purdue Pharma L.P. Description and Business Overview
11.1.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Purdue Pharma L.P. Opioids Products Offered
11.1.5 Purdue Pharma L.P. Related Developments
11.2 West-Ward Pharmaceuticals Corporation
11.2.1 West-Ward Pharmaceuticals Corporation Corporation Information
11.2.2 West-Ward Pharmaceuticals Corporation Description and Business Overview
11.2.3 West-Ward Pharmaceuticals Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 West-Ward Pharmaceuticals Corporation Opioids Products Offered
11.2.5 West-Ward Pharmaceuticals Corporation Related Developments
11.3 Allergan
11.3.1 Allergan Corporation Information
11.3.2 Allergan Description and Business Overview
11.3.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Allergan Opioids Products Offered
11.3.5 Allergan Related Developments
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Corporation Information
11.4.2 Pfizer, Inc. Description and Business Overview
11.4.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer, Inc. Opioids Products Offered
11.4.5 Pfizer, Inc. Related Developments
11.5 Janssen Pharmaceuticals, Inc.
11.5.1 Janssen Pharmaceuticals, Inc. Corporation Information
11.5.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
11.5.3 Janssen Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Janssen Pharmaceuticals, Inc. Opioids Products Offered
11.5.5 Janssen Pharmaceuticals, Inc. Related Developments
11.6 Egalet Corporation
11.6.1 Egalet Corporation Corporation Information
11.6.2 Egalet Corporation Description and Business Overview
11.6.3 Egalet Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Egalet Corporation Opioids Products Offered
11.6.5 Egalet Corporation Related Developments
11.7 Sun Pharmaceutical Industries Limited.
11.7.1 Sun Pharmaceutical Industries Limited. Corporation Information
11.7.2 Sun Pharmaceutical Industries Limited. Description and Business Overview
11.7.3 Sun Pharmaceutical Industries Limited. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sun Pharmaceutical Industries Limited. Opioids Products Offered
11.7.5 Sun Pharmaceutical Industries Limited. Related Developments
11.1 Purdue Pharma L.P.
11.1.1 Purdue Pharma L.P. Corporation Information
11.1.2 Purdue Pharma L.P. Description and Business Overview
11.1.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Purdue Pharma L.P. Opioids Products Offered
11.1.5 Purdue Pharma L.P. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Opioids Market Estimates and Projections by Region
12.1.1 Global Opioids Sales Forecast by Regions 2021-2026
12.1.2 Global Opioids Revenue Forecast by Regions 2021-2026
12.2 North America Opioids Market Size Forecast (2021-2026)
12.2.1 North America: Opioids Sales Forecast (2021-2026)
12.2.2 North America: Opioids Revenue Forecast (2021-2026)
12.2.3 North America: Opioids Market Size Forecast by Country (2021-2026)
12.3 Europe Opioids Market Size Forecast (2021-2026)
12.3.1 Europe: Opioids Sales Forecast (2021-2026)
12.3.2 Europe: Opioids Revenue Forecast (2021-2026)
12.3.3 Europe: Opioids Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Opioids Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Opioids Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Opioids Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Opioids Market Size Forecast by Region (2021-2026)
12.5 Latin America Opioids Market Size Forecast (2021-2026)
12.5.1 Latin America: Opioids Sales Forecast (2021-2026)
12.5.2 Latin America: Opioids Revenue Forecast (2021-2026)
12.5.3 Latin America: Opioids Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Opioids Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Opioids Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Opioids Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Opioids Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Opioids Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioids Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Opioids Market Segments
Table 2. Ranking of Global Top Opioids Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Opioids Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Immediate-Release/Short-Acting Opioid
Table 5. Major Manufacturers of Extended-Release/Long-Acting Opioid
Table 6. Global Opioids Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Opioids Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Opioids Sales by Regions 2015-2020 (MT)
Table 9. Global Opioids Sales Market Share by Regions (2015-2020)
Table 10. Global Opioids Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Opioids Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Opioids Sales Share by Manufacturers (2015-2020)
Table 13. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Opioids by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids as of 2019)
Table 15. Opioids Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Opioids Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Opioids Price (2015-2020) (USD/Kg)
Table 18. Opioids Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Opioids Product Type
Table 20. Date of International Manufacturers Enter into Opioids Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Opioids Sales by Type (2015-2020) (MT)
Table 23. Global Opioids Sales Share by Type (2015-2020)
Table 24. Global Opioids Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Opioids Revenue Share by Type (2015-2020)
Table 26. Opioids Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 27. Global Opioids Sales by Application (2015-2020) (MT)
Table 28. Global Opioids Sales Share by Application (2015-2020)
Table 29. North America Opioids Sales by Country (2015-2020) (MT)
Table 30. North America Opioids Sales Market Share by Country (2015-2020)
Table 31. North America Opioids Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Opioids Revenue Market Share by Country (2015-2020)
Table 33. North America Opioids Sales by Type (2015-2020) (MT)
Table 34. North America Opioids Sales Market Share by Type (2015-2020)
Table 35. North America Opioids Sales by Application (2015-2020) (MT)
Table 36. North America Opioids Sales Market Share by Application (2015-2020)
Table 37. Europe Opioids Sales by Country (2015-2020) (MT)
Table 38. Europe Opioids Sales Market Share by Country (2015-2020)
Table 39. Europe Opioids Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Opioids Revenue Market Share by Country (2015-2020)
Table 41. Europe Opioids Sales by Type (2015-2020) (MT)
Table 42. Europe Opioids Sales Market Share by Type (2015-2020)
Table 43. Europe Opioids Sales by Application (2015-2020) (MT)
Table 44. Europe Opioids Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Opioids Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Opioids Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Opioids Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Opioids Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Opioids Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Opioids Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Opioids Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Opioids Sales Market Share by Application (2015-2020)
Table 53. Latin America Opioids Sales by Country (2015-2020) (MT)
Table 54. Latin America Opioids Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Opioids Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Opioids Revenue Market Share by Country (2015-2020)
Table 57. Latin America Opioids Sales by Type (2015-2020) (MT)
Table 58. Latin America Opioids Sales Market Share by Type (2015-2020)
Table 59. Latin America Opioids Sales by Application (2015-2020) (MT)
Table 60. Latin America Opioids Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Opioids Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Opioids Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Opioids Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Opioids Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Opioids Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Opioids Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Opioids Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Opioids Sales Market Share by Application (2015-2020)
Table 69. Purdue Pharma L.P. Corporation Information
Table 70. Purdue Pharma L.P. Description and Major Businesses
Table 71. Purdue Pharma L.P. Opioids Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 72. Purdue Pharma L.P. Product
Table 73. Purdue Pharma L.P. Recent Development
Table 74. West-Ward Pharmaceuticals Corporation Corporation Information
Table 75. West-Ward Pharmaceuticals Corporation Description and Major Businesses
Table 76. West-Ward Pharmaceuticals Corporation Opioids Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. West-Ward Pharmaceuticals Corporation Product
Table 78. West-Ward Pharmaceuticals Corporation Recent Development
Table 79. Allergan Corporation Information
Table 80. Allergan Description and Major Businesses
Table 81. Allergan Opioids Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Allergan Product
Table 83. Allergan Recent Development
Table 84. Pfizer, Inc. Corporation Information
Table 85. Pfizer, Inc. Description and Major Businesses
Table 86. Pfizer, Inc. Opioids Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Pfizer, Inc. Product
Table 88. Pfizer, Inc. Recent Development
Table 89. Janssen Pharmaceuticals, Inc. Corporation Information
Table 90. Janssen Pharmaceuticals, Inc. Description and Major Businesses
Table 91. Janssen Pharmaceuticals, Inc. Opioids Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Janssen Pharmaceuticals, Inc. Product
Table 93. Janssen Pharmaceuticals, Inc. Recent Development
Table 94. Egalet Corporation Corporation Information
Table 95. Egalet Corporation Description and Major Businesses
Table 96. Egalet Corporation Opioids Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Egalet Corporation Product
Table 98. Egalet Corporation Recent Development
Table 99. Sun Pharmaceutical Industries Limited. Corporation Information
Table 100. Sun Pharmaceutical Industries Limited. Description and Major Businesses
Table 101. Sun Pharmaceutical Industries Limited. Opioids Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Sun Pharmaceutical Industries Limited. Product
Table 103. Sun Pharmaceutical Industries Limited. Recent Development
Table 104. Global Opioids Sales Forecast by Regions (2021-2026) (MT)
Table 105. Global Opioids Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Opioids Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Opioids Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Opioids Sales Forecast by Country (2021-2026) (MT)
Table 109. North America: Opioids Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Opioids Sales Forecast by Country (2021-2026) (MT)
Table 111. Europe: Opioids Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Opioids Sales Forecast by Region (2021-2026) (MT)
Table 113. Asia Pacific: Opioids Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Opioids Sales Forecast by Country (2021-2026) (MT)
Table 115. Latin America: Opioids Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Opioids Sales Forecast by Country (2021-2026) (MT)
Table 117. Middle East and Africa: Opioids Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Opioids Players
Table 122. Opioids Customers List
Table 123. Opioids Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Product Picture
Figure 2. Global Opioids Sales Market Share by Type in 2020 & 2026
Figure 3. Immediate-Release/Short-Acting Opioid Product Picture
Figure 4. Extended-Release/Long-Acting Opioid Product Picture
Figure 5. Global Opioids Sales Market Share by Application in 2020 & 2026
Figure 6. Pain Relief
Figure 7. Anesthesia
Figure 8. Cough Suppression
Figure 9. Diarrhea Suppression
Figure 10. Deaddiction
Figure 11. Opioids Report Years Considered
Figure 12. Global Opioids Market Size 2015-2026 (US$ Million)
Figure 13. Global Opioids Sales 2015-2026 (MT)
Figure 14. Global Opioids Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Opioids Sales Market Share by Region (2015-2020)
Figure 16. Global Opioids Sales Market Share by Region in 2019
Figure 17. Global Opioids Revenue Market Share by Region (2015-2020)
Figure 18. Global Opioids Revenue Market Share by Region in 2019
Figure 19. Global Opioids Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Opioids Revenue in 2019
Figure 21. Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Opioids Sales Market Share by Type (2015-2020)
Figure 23. Global Opioids Sales Market Share by Type in 2019
Figure 24. Global Opioids Revenue Market Share by Type (2015-2020)
Figure 25. Global Opioids Revenue Market Share by Type in 2019
Figure 26. Global Opioids Market Share by Price Range (2015-2020)
Figure 27. Global Opioids Sales Market Share by Application (2015-2020)
Figure 28. Global Opioids Sales Market Share by Application in 2019
Figure 29. Global Opioids Revenue Market Share by Application (2015-2020)
Figure 30. Global Opioids Revenue Market Share by Application in 2019
Figure 31. North America Opioids Sales Growth Rate 2015-2020 (MT)
Figure 32. North America Opioids Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Opioids Sales Market Share by Country in 2019
Figure 34. North America Opioids Revenue Market Share by Country in 2019
Figure 35. U.S. Opioids Sales Growth Rate (2015-2020) (MT)
Figure 36. U.S. Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Opioids Sales Growth Rate (2015-2020) (MT)
Figure 38. Canada Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Opioids Market Share by Type in 2019
Figure 40. North America Opioids Market Share by Application in 2019
Figure 41. Europe Opioids Sales Growth Rate 2015-2020 (MT)
Figure 42. Europe Opioids Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Opioids Sales Market Share by Country in 2019
Figure 44. Europe Opioids Revenue Market Share by Country in 2019
Figure 45. Germany Opioids Sales Growth Rate (2015-2020) (MT)
Figure 46. Germany Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Opioids Sales Growth Rate (2015-2020) (MT)
Figure 48. France Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Opioids Sales Growth Rate (2015-2020) (MT)
Figure 50. U.K. Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Opioids Sales Growth Rate (2015-2020) (MT)
Figure 52. Italy Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Opioids Sales Growth Rate (2015-2020) (MT)
Figure 54. Russia Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Opioids Market Share by Type in 2019
Figure 56. Europe Opioids Market Share by Application in 2019
Figure 57. Asia Pacific Opioids Sales Growth Rate 2015-2020 (MT)
Figure 58. Asia Pacific Opioids Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Opioids Sales Market Share by Region in 2019
Figure 60. Asia Pacific Opioids Revenue Market Share by Region in 2019
Figure 61. China Opioids Sales Growth Rate (2015-2020) (MT)
Figure 62. China Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Opioids Sales Growth Rate (2015-2020) (MT)
Figure 64. Japan Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Opioids Sales Growth Rate (2015-2020) (MT)
Figure 66. South Korea Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Opioids Sales Growth Rate (2015-2020) (MT)
Figure 68. India Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Opioids Sales Growth Rate (2015-2020) (MT)
Figure 70. Australia Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Opioids Sales Growth Rate (2015-2020) (MT)
Figure 72. Taiwan Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Opioids Sales Growth Rate (2015-2020) (MT)
Figure 74. Indonesia Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Opioids Sales Growth Rate (2015-2020) (MT)
Figure 76. Thailand Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Opioids Sales Growth Rate (2015-2020) (MT)
Figure 78. Malaysia Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Opioids Sales Growth Rate (2015-2020) (MT)
Figure 80. Philippines Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Opioids Sales Growth Rate (2015-2020) (MT)
Figure 82. Vietnam Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Opioids Market Share by Type in 2019
Figure 84. Asia Pacific Opioids Market Share by Application in 2019
Figure 85. Latin America Opioids Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Opioids Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Opioids Sales Market Share by Country in 2019
Figure 88. Latin America Opioids Revenue Market Share by Country in 2019
Figure 89. Mexico Opioids Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Opioids Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Opioids Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Opioids Market Share by Type in 2019
Figure 96. Latin America Opioids Market Share by Application in 2019
Figure 97. Middle East and Africa Opioids Sales Growth Rate 2015-2020 (MT)
Figure 98. Middle East and Africa Opioids Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Opioids Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Opioids Revenue Market Share by Country in 2019
Figure 101. Turkey Opioids Sales Growth Rate (2015-2020) (MT)
Figure 102. Turkey Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Opioids Sales Growth Rate (2015-2020) (MT)
Figure 104. Saudi Arabia Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Opioids Sales Growth Rate (2015-2020) (MT)
Figure 106. U.A.E Opioids Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Opioids Market Share by Type in 2019
Figure 108. Middle East and Africa Opioids Market Share by Application in 2019
Figure 109. North America Opioids Sales Growth Rate Forecast (2021-2026) (MT)
Figure 110. North America Opioids Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Opioids Sales Growth Rate Forecast (2021-2026) (MT)
Figure 112. Europe Opioids Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Opioids Sales Growth Rate Forecast (2021-2026) (MT)
Figure 114. Asia Pacific Opioids Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Opioids Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. Latin America Opioids Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Opioids Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Middle East and Africa Opioids Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs